Malecare Prostate Cancer Support Group

Malecare

About Malecare

This author has not yet filled in any details.
So far Malecare has created 608 blog entries.

Phase III Trial Comparing Orteronel (TAK-700) Plus Prednisone Against Placebo Plus Prednisone Fails

Reporting both negative clinical trial results is as important as reporting positive results. However, pharmaceutical companies often bury negative results. Fortunately (actually unfortunately because there were negative results) a Phase III, randomized, double-blind, multicenter trial comparing orteronel (TAK-700) plus prednisone with placebo plus prednisone in men with metastatic castration-resistant prostate cancer (mCRPC) that has progressed [...]

By |2020-02-04T11:36:51-05:00April 3rd, 2015|Advanced Prostate Cancer, Clinical Trials, Clinical Trials, TAK700, Uncategorized|0 Comments
Read More

Lethal Advanced Prostate Cancer Has Inherently Heterogeneity And Can Spread From Other Metastatic Sites

We still have a lot to learn about how prostate cancer actually spreads, or metastasizes. Current theory holds that the primary tumor is probably most responsible for the development of distant metastases. In a new genomic analysis of tissue performed at the Johns Hopkins University using tissue from prostate cancer patients this paradigm has been [...]

By |2020-02-04T11:15:49-05:00April 2nd, 2015|Advanced Prostate Cancer, Drugs & Treatments, genetics, Metastases, Uncategorized, Understanding APC|0 Comments
Read More

Controversy at ASCO GU: Conflicting Randomized Trials on Docetaxel Plus ADT for Hormone Sensitive Metastatic Prostate Cancer *

Last year after the ASCO meeting in Chicago I declared that there was one particular presentation of the CHAARTED trial that would be a game changer for the treatment of newly diagnosed men with very significant prostate cancer. The game changer was that men diagnosed with significant disease and who were still ADT naive (not [...]

By |2020-02-04T10:39:13-05:00April 1st, 2015|Advanced Prostate Cancer, ASCO, Chemo Therapy, Clinical Trials, Clinical Trials, Drugs & Treatments, Hormone Therapy, taxotere, Uncategorized, Understanding APC|0 Comments
Read More

Using CT Scans to Predict A Pending Spinal Cord Compression in Men With Castration-Resistant Prostate Cancer *

CT scans are often performed in the process of monitoring of advanced prostate cancer disease progression. One of the most serious impacts of advanced prostate cancer is spinal compression, which can lead to paralysis and significant pain. Being able to use the CT scan as a red flag warning about potential spinal cord compression could [...]

By |2020-02-04T12:41:01-05:00March 31st, 2015|Advanced Prostate Cancer, Bone Metastases, CT Scans, General Information, Research, Scanning Technology, Spinal Cord Compression, Uncategorized|1 Comment
Read More

Detecting Prostate Cancer Cells in Blood Can Give An Early Warning of Treatment Failure and Shorten Clinical Trials

There is more evidence that the blood test used to count the number of cells circulating in the blood and shed from prostate tumors (circulating tumor cells or CTCs) can indicate whether a treatment is working or not working. A major new study showed that the number of these circulating tumor cells in the blood [...]

By |2017-10-19T10:47:29-04:00March 27th, 2015|Advanced Prostate Cancer, Clinical Trials, Clinical Trials, CTCs, General Information, On The Horizon, Uncategorized, Understanding APC, Zytiga|0 Comments
Read More
Go to Top